Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
STEAD
Show more
Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services
Class 42 – Technology & SaaS
Status timeline
- 31 Jan 2022Application filedNew Application Entered
- 1 Jun 2022Assigned to an examining attorneyAssigned To Examiner
- 6 Jun 2022Office action issuedNon-Final Action Written
- 1 Dec 2022Approved for publicationApproved For Pub - Principal Register
- 3 Jan 2023Published for oppositionPublished For Opposition
- 28 Feb 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 24 Aug 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 29 Jan 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 31 Jul 2024Statement-of-use extension 3 grantedSou Extension 3 Granted
- 25 Feb 2026Statement of use filedTeas Statement Of Use Received
- 27 Feb 2026Statement of use acceptedAllowed Principal Register - Sou Accepted
- 24 Mar 2026Registered on the Principal RegisterRegistered-Principal Register
All 47 events
| 2026-03-24 | Registered-Principal Register |
| 2026-03-24 | Notice Of Registration Confirmation Emailed |
| 2026-02-27 | Allowed Principal Register - Sou Accepted |
| 2026-02-27 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2026-02-26 | Statement Of Use Processing Complete |
| 2026-02-25 | Teas Statement Of Use Received |
| 2026-02-25 | Use Amendment Filed |
| 2025-12-18 | Case Assigned To Intent To Use Paralegal |
| 2025-12-18 | Sou Extension 5 Granted |
| 2025-12-18 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-07-29 | Sou Teas Extension Received |
| 2025-07-29 | Sou Extension 5 Filed |
| 2025-03-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-01-25 | Sou Extension 4 Filed |
| 2025-01-25 | Sou Extension 4 Granted |
| 2025-01-24 | Sou Teas Extension Received |
| 2024-07-31 | Sou Teas Extension Received |
| 2024-07-31 | Sou Extension 3 Filed |
| 2024-07-31 | Sou Extension 3 Granted |
| 2024-07-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-01-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-01-29 | Sou Teas Extension Received |
| 2024-01-29 | Sou Extension 2 Filed |
| 2024-01-29 | Sou Extension 2 Granted |
| 2023-09-22 | Teas Change Of Owner Address Received |
| 2023-09-22 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2023-09-22 | Teas Change Of Correspondence Received |
| 2023-08-26 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-08-24 | Sou Teas Extension Received |
| 2023-08-24 | Sou Extension 1 Filed |
| 2023-08-24 | Sou Extension 1 Granted |
| 2023-02-28 | Noa Mailed - Sou Required From Applicant |
| 2023-01-03 | Published For Opposition |
| 2023-01-03 | Official Gazette Publication Confirmation E-Mailed |
| 2022-12-14 | Notification Of Notice Of Publication E-Mailed |
| 2022-12-01 | Approved For Pub - Principal Register |
| 2022-11-30 | Assigned To Lie |
| 2022-11-30 | Examiner's Amendment Entered |
| 2022-11-29 | Examiners Amendment -Written |
| 2022-11-29 | Examiners Amendment E-Mailed |
| 2022-11-29 | Notification Of Examiners Amendment E-Mailed |
| 2022-06-06 | Non-Final Action Written |
| 2022-06-06 | Non-Final Action E-Mailed |
| 2022-06-06 | Notification Of Non-Final Action E-Mailed |
| 2022-06-01 | Assigned To Examiner |
| 2022-02-01 | New Application Office Supplied Data Entered |
| 2022-01-31 | New Application Entered |
Goods & services by class
Class 42 Technology & SaaS
Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services
First use anywhere 31 May 2025 · First use in commerce 31 May 2025
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 25 Mar 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.